Hepatitis D - Pharmacological Therapy
- Interferon alfa is the only approved chronic hepatitis D treatment and Peginterferon is the drug of choice
- Peginterferon alfa is recommended to be given for 48 weeks in patients with elevated ALT and HDV RNA levels
- Endpoint of therapy is the achievement of a complete virological response, ie undetectable HBsAg with sustained suppression of HDV RNA